002007 Hualan Biological Engineering, Inc.
- 17.03
- -0.31-1.79%
Hualan Biological Engineering, Inc. News
Hualan Biotech: Announcement on the company\'s acquisition of a single plasma sampling license
Hualan Biotech: Announcement on the Shareholding Company Obtaining an Acceptance Notice for Drug Registration
Hualan Biotech: Announcement on participating companies obtaining drug registration certificates
Hualan Biotech: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Hualan Biological Engineering, Inc.: Notice on the approval of the establishment of a single blood plasma collection station by a wholly-owned subsidiary.
Hualan Biological Engineering, Inc.: Announcement regarding the price adjustment of the main products of the holding subsidiary.
Hualan Biological Engineering, Inc.: Announcement on the company's acquisition of a single plasma sampling license
Hualan Biotech: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Hualan Bioengineering Co., Ltd.
Hualan Biology: Legal Opinion of Anhui Chengyi Law Firm on Hualan Bioengineering Co., Ltd. holding the 2023 Annual General Meeting of Shareholders
Hualan Biotech: “Rules of Procedure for the Nomination Committee of the Board of Directors”
Hualan Biotech: “Rules of Work of the Board Strategy Committee”
Hualan Biotech: Rules of Procedure for the Board of Directors of Hualan Bioengineering Co., Ltd.
Hualan Biotech: The company's shareholder return plan for the next three years (2024-2026)
Hualan Biology: Internal Control Self-Evaluation Report
Hualan Biotech: “Rules of Work for the Audit Committee of the Board of Directors”
Hualan Biotech: Notice of Annual General Meeting of Shareholders
Hualan Biotech: Announcement on the use of own funds for investment and financial management
Hualan Biotech: Notice on amending the “Articles of Association” and its annexes
Hualan Biology: “Rules of Work of the Remuneration and Assessment Committee of the Board of Directors”
Hualan Biotech: Announcement on the Action Plan to Promote “Double Improvement of Quality and Return”
No Data
